Index NDX, S&P 500
P/E 105.19
EPS (ttm) 1.31
Insider Own 2.10%
Shs Outstand 385.40M
Perf Week 3.00%
Market Cap 53.15B
Forward P/E 61.62
EPS next Y 2.24
Insider Trans -3.37%
Shs Float 377.42M
Perf Month -1.59%
Income 541.50M
PEG 3.15
EPS next Q 0.27
Inst Own 99.35%
Short Float 3.86%
Perf Quarter 8.20%
Sales 3.62B
P/S 14.67
EPS this Y 15.91%
Inst Trans -0.36%
Short Ratio 4.80
Perf Half Y 60.28%
Book/sh 5.37
P/B 25.69
EPS next Y 26.99%
ROA 9.29%
Short Interest 14.57M
Perf Year 11.34%
Cash/sh 7.07
P/C 19.51
EPS next 5Y 33.40%
ROE 25.78%
52W Range 74.75 - 142.00
Perf YTD 11.10%
Dividend Est. -
P/FCF 103.83
EPS past 5Y -
ROI 11.67%
52W High -2.91%
Beta 1.21
Dividend TTM -
Quick Ratio 2.48
Sales past 5Y 28.80%
Gross Margin 63.11%
52W Low 84.44%
ATR (14) 4.18
Dividend Ex-Date -
Current Ratio 2.84
EPS Y/Y TTM 60.16%
Oper. Margin 16.50%
RSI (14) 56.14
Volatility 3.25% 2.95%
Employees 9600
Debt/Eq 1.25
Sales Y/Y TTM 24.49%
Profit Margin 14.95%
Recom 1.32
Target Price 151.03
Option/Short Yes / Yes
LT Debt/Eq 1.24
EPS Q/Q 189.33%
Payout 0.00%
Rel Volume 1.07
Prev Close 134.00
Sales Surprise 1.89%
EPS Surprise 16.09%
Sales Q/Q 26.90%
Earnings Apr 25 AMC
Avg Volume 3.04M
Price 137.87
SMA20 0.80%
SMA50 6.26%
SMA200 19.82%
Trades
Volume 3,235,230
Change 2.89%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-12-24 Initiated
RBC Capital Mkts
Outperform
$165
May-30-23 Resumed
Morgan Stanley
Equal-Weight
$131
Apr-17-23 Upgrade
Raymond James
Outperform → Strong Buy
$127 → $138
Mar-29-23 Initiated
UBS
Buy
$142
Jan-26-23 Initiated
Wolfe Research
Outperform
$121
Oct-18-22 Initiated
Barclays
Equal Weight
$103
Oct-12-22 Initiated
Jefferies
Buy
$125
Jul-15-22 Initiated
Bernstein
Outperform
$105
Mar-02-22 Resumed
BofA Securities
Buy
$500
Feb-03-22 Upgrade
BTIG Research
Neutral → Buy
$535
Jan-19-22 Upgrade
Wells Fargo
Equal Weight → Overweight
$575
Jan-07-22 Upgrade
Guggenheim
Neutral → Buy
$580
Oct-18-21 Downgrade
Guggenheim
Buy → Neutral
Jul-21-21 Resumed
Cowen
Outperform
$540 → $525
May-28-21 Upgrade
Wells Fargo
Underweight → Equal Weight
$380
May-25-21 Initiated
Barclays
Overweight
$500
Apr-15-21 Initiated
Atlantic Equities
Overweight
$438
Jan-06-21 Upgrade
UBS
Neutral → Buy
$410 → $445
Oct-02-20 Downgrade
Wells Fargo
Equal Weight → Underweight
$420 → $350
May-27-20 Reiterated
Piper Sandler
Overweight
$375 → $450
Show Previous Ratings
Today 09:30AM
Apr-23-24 09:29AM
06:14AM
Apr-22-24 09:16AM
Apr-21-24 10:49AM
02:39PM
Loading…
Apr-19-24 02:39PM
(Investor's Business Daily)
08:30AM
(Investor's Business Daily)
Apr-18-24 08:26AM
Apr-16-24 07:00PM
04:13AM
Apr-15-24 06:15PM
10:54AM
Apr-12-24 08:00AM
(Investor's Business Daily)
Apr-11-24 09:40AM
Apr-10-24 07:00PM
04:00PM
Loading…
04:00PM
03:41PM
09:27AM
Apr-08-24 06:00PM
02:44PM
(Investor's Business Daily)
08:30AM
Apr-04-24 09:00AM
Apr-03-24 10:14AM
09:00AM
Apr-02-24 06:00PM
08:30AM
Apr-01-24 04:48PM
Mar-30-24 01:55AM
Mar-29-24 12:00PM
01:44AM
03:03PM
Loading…
Mar-27-24 03:03PM
(Investor's Business Daily)
10:56AM
07:02AM
Mar-26-24 07:00PM
06:00PM
01:56PM
(Investor's Business Daily)
09:40AM
08:02AM
05:10AM
Mar-25-24 04:21PM
(Investor's Business Daily) +5.20%
04:21PM
(Investor's Business Daily)
Mar-23-24 08:00AM
(Investor's Business Daily)
Mar-21-24 09:00AM
Mar-20-24 07:44PM
04:02AM
Mar-19-24 07:00PM
06:00PM
Mar-18-24 02:47PM
(Investor's Business Daily)
09:29AM
08:55AM
Mar-14-24 09:30AM
Mar-13-24 04:43PM
(Investor's Business Daily)
Mar-11-24 06:00PM
Mar-08-24 09:15AM
07:57AM
05:41AM
Mar-07-24 09:40AM
09:00AM
08:00AM
07:37AM
06:38AM
06:29AM
06:20AM
05:27AM
03:43AM
Mar-06-24 07:03PM
(Morningstar Research) +9.80%
05:18PM
04:50PM
04:15PM
(Investor's Business Daily)
02:58PM
01:08PM
11:36AM
(Investor's Business Daily)
10:25AM
(Investor's Business Daily)
08:45AM
Mar-05-24 11:39PM
05:50PM
04:49PM
04:26PM
03:00AM
Mar-04-24 06:00PM
06:43AM
Mar-03-24 10:15AM
Feb-27-24 04:05PM
09:30AM
Feb-26-24 01:46PM
Feb-23-24 09:00AM
Feb-22-24 09:53AM
Feb-21-24 11:53PM
09:12AM
Feb-18-24 04:33PM
01:26PM
Feb-14-24 02:43PM
Feb-13-24 07:13PM
05:27AM
02:42AM
Feb-12-24 05:06AM
Feb-10-24 08:30AM
Feb-09-24 09:38AM
09:31AM
06:40AM
(Thomson Reuters StreetEvents)
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Dolan Matthew Vincent EVP Strategy and Corporate Dev Apr 15 '24 Sale 137.81 1,990 274,242 42,377 Apr 16 04:16 PM SAYER KEVIN R President CEO and Chairman Apr 08 '24 Sale 138.30 49,633 6,864,136 283,893 Apr 10 04:04 PM Brown Michael Jon EVP Chief Legal Officer Mar 28 '24 Sale 140.04 2,624 367,472 68,682 Mar 29 07:30 PM Stern Sadie EVP Chief Human Resources Mar 25 '24 Sale 140.00 4,137 579,180 76,304 Mar 26 04:46 PM Dolan Matthew Vincent EVP Strategy & Corp Dev Mar 15 '24 Sale 130.21 4,203 547,259 44,367 Mar 19 04:55 PM SAYER KEVIN R President CEO and Chairman Mar 12 '24 Sale 133.36 81,007 10,802,803 333,526 Mar 14 05:40 PM Stern Sadie EVP Chief Human Resources Mar 12 '24 Sale 133.61 20,321 2,715,006 80,441 Mar 14 05:40 PM Leach Jacob Steven EVP Chief Operating Officer Mar 12 '24 Sale 134.41 14,639 1,967,638 273,913 Mar 14 05:40 PM Sylvain Jereme M EVP Chief Financial Officer Mar 12 '24 Sale 134.41 11,661 1,567,363 85,534 Mar 14 05:40 PM Brown Michael Jon EVP Chief Legal Officer Mar 12 '24 Sale 134.41 8,799 1,182,680 71,306 Mar 14 05:39 PM Dolan Matthew Vincent EVP Strategy and Corporate Mar 12 '24 Sale 134.41 6,710 901,896 48,570 Mar 14 05:39 PM Lawver Teri L EVP Chief Commercial Officer Mar 12 '24 Sale 134.41 4,764 640,333 66,641 Mar 14 05:39 PM Sylvain Jereme M EVP Chief Financial Officer Feb 20 '24 Sale 116.73 3,363 392,563 71,142 Feb 21 05:48 PM SAYER KEVIN R President, CEO and Chairman Jan 16 '24 Sale 123.63 37,325 4,614,669 362,841 Jan 17 06:49 PM Leach Jacob Steven EVP Chief Operating Officer Jan 16 '24 Sale 123.63 3,978 491,819 262,499 Jan 17 06:49 PM Stern Sadie EVP Chief Human Resources Jan 16 '24 Sale 123.63 2,902 358,788 79,051 Jan 17 06:56 PM Sylvain Jereme M EVP Chief Financial Officer Jan 16 '24 Sale 123.63 2,734 338,018 74,505 Jan 17 06:54 PM ALTMAN STEVEN R Director Jan 16 '24 Sale 122.86 1,568 192,652 53,132 Jan 17 06:47 PM AUGUSTINOS NICHOLAS Director Dec 15 '23 Sale 123.02 3,976 489,128 34,040 Dec 18 04:32 PM ALTMAN STEVEN R Director Dec 15 '23 Sale 122.77 2,000 245,548 54,700 Dec 18 04:31 PM ALTMAN STEVEN R Director Dec 12 '23 Sale 120.00 3,000 360,004 56,700 Dec 13 04:18 PM Stern Sadie EVP Chief Human Resources Offi Dec 11 '23 Sale 117.66 392 46,123 76,008 Dec 11 06:15 PM Brown Michael Jon EVP Chief Legal Officer Dec 01 '23 Sale 114.56 3,612 413,774 58,394 Dec 04 06:10 PM Pacelli Steven Robert EVP Managing Director Dexcom V Nov 24 '23 Sale 110.80 411 45,539 124,775 Nov 27 04:00 PM Stern Sadie EVP Chief Human Resources Offi Nov 22 '23 Sale 110.00 1,176 129,360 76,400 Nov 24 03:51 PM ALTMAN STEVEN R Director Nov 15 '23 Sale 101.26 1,000 101,256 59,700 Nov 15 06:36 PM Naganathan Girish EVP Chief Technology Officer Nov 09 '23 Sale 93.27 2,725 254,161 47,725 Nov 27 07:34 PM Regan Barry J. EVP Operations Nov 08 '23 Sale 95.22 2,019 192,249 64,250 Nov 08 04:05 PM Pacelli Steven Robert EVP Managing Director Dexcom V Oct 23 '23 Sale 85.75 411 35,243 125,186 Oct 23 07:43 PM ALTMAN STEVEN R Director Oct 16 '23 Sale 77.58 1,000 77,580 60,700 Oct 17 04:15 PM Pacelli Steven Robert EVP Managing Director Dexcom V Sep 22 '23 Sale 88.40 411 36,332 125,597 Sep 22 06:30 PM ALTMAN STEVEN R Director Sep 15 '23 Sale 101.50 1,000 101,495 61,700 Sep 19 04:43 PM Heller Bridgette P Director Sep 12 '23 Sale 106.56 600 63,936 23,731 Sep 13 07:55 PM Dolan Matthew Vincent SVP Corporate Strategy-Develop Sep 01 '23 Sale 102.32 56 5,730 33,569 Sep 01 06:40 PM Pacelli Steven Robert EVP Managing Director Dexcom V Aug 23 '23 Sale 107.03 411 43,989 126,008 Aug 23 05:42 PM Sylvain Jereme M EVP Chief Financial Officer Aug 22 '23 Sale 104.38 1,844 192,477 72,867 Aug 22 04:04 PM Stern Sadie EVP Chief Human Resources Offi Aug 09 '23 Sale 110.71 392 43,398 81,682 Aug 11 03:59 PM Pacelli Steven Robert EVP Managing Director Dexcom V Jul 24 '23 Sale 130.58 412 53,799 126,419 Jul 24 05:18 PM Pacelli Steven Robert EVP Managing Director Dexcom V Jul 14 '23 Sale 136.00 5,031 684,216 126,831 Jul 17 04:54 PM Regan Barry J. EVP Operations Jul 10 '23 Sale 128.05 1,989 254,691 66,269 Jul 10 05:39 PM Stern Sadie EVP Chief Human Resources Offi Jul 10 '23 Sale 128.05 392 50,196 82,074 Jul 10 05:40 PM Pacelli Steven Robert EVP Managing Director Dexcom V Jun 23 '23 Sale 125.92 412 51,879 131,862 Jun 26 04:16 PM Selvaraj Shelly Ramasamy SVP Chief Information Officer Jun 15 '23 Sale 130.00 2,115 274,953 50,390 Jun 15 05:16 PM Stern Sadie EVP Chief Human Resources Offi Jun 09 '23 Sale 121.31 393 47,675 82,466 Jun 12 04:32 PM Pacelli Steven Robert EVP Managing Director Dexcom V May 23 '23 Sale 118.65 412 48,884 132,274 May 23 07:13 PM Sylvain Jereme M EVP Chief Financial Officer May 22 '23 Sale 117.58 2,400 282,192 74,711 May 23 07:12 PM Stern Sadie EVP Chief Human Resources Offi May 09 '23 Sale 120.19 393 47,235 82,859 May 09 06:24 PM Pacelli Steven Robert EVP Managing Director Dexcom V Apr 27 '23 Sale 126.00 5,031 633,906 132,686 Apr 27 06:38 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite